| Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46 |
| Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q |
| Ref : Int J Clin Pract , 63 :46 , 2009 |
| Abstract : Nauck_2009_Int.J.Clin.Pract_63_46 |
| ESTHER : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedID: 19125992 |
Nauck MA, Ellis GC, Fleck PR, Wilson CA, Mekki Q (2009)
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study
Int J Clin Pract
63 :46
Nauck MA, Ellis GC, Fleck PR, Wilson CA, Mekki Q (2009)
Int J Clin Pract
63 :46